February 20, 2013 (SACRAMENTO, Calif.) — A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer patients, UC Davis researchers have found. Paramita Ghosh… Read More ›
Androgen deprivation therapy
Androgen deprivation therapy for localized prostate cancer not associated with improved survival
Re-Post 2008 Contact: Michele Fisher 732-235-9872 JAMA and Archives Journals A therapy that involves depriving the prostate gland the male hormone androgen is not associated with improved survival for elderly men with localized prostate cancer, compared to conservative management of… Read More ›
35th Health Research Report 22 JUL 2008 – Reconstruction
Editors Top Five: 1. Environmental pollutant has sex-skewing effect 2. Stomach bug appears to protect kids from asthma, says NYU study 3. Cranberry juice creates energy barrier that keeps bacteria away from cells, study shows 4. 89 percent of… Read More ›
32nd Health Research Report 11 JUN 2008 – Reconstructed
32nd Health Research Report 11 JUN 2008 – Reconstructed Editors Top Five: 1. US reporters often do a poor job of reporting about new medical treatments 2. Pycnogenol improved diabetes control and reduced antihypertensive medications 3. How advanced prostate cancer… Read More ›
Standard treatment for prostate cancer may encourage spread of disease
Contact: Christen Brownlee cbrownlee@jhmi.edu 410-955-7832 Johns Hopkins Medical Institutions Finding may lead to changes in androgen deprivation therapy A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more… Read More ›
Engineering Evil 